Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wockhardt Ltd Capital/Financing Update 2021

Sep 30, 2021

59231_rns_2021-09-30_b87dc2c2-08b1-4af2-8f6e-e44c668c1a1d.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [167 x 46] intentionally omitted <==

30[th] September, 2021

BSE LimitedCorporate Relations DepartmentP J Towers,Dalal StreetMumbai - 400 001Scrip Code: 532300 National Stock Exchange of India LimitedListing DepartmentExchange PlazaBandra Kurla Complex, Bandra (E),Mumbai - 400 051NSE Symbol– WOCKPHARMA

Dear Sir/ Madam,

Sub: Affirmation of Credit Rating by India Ratings

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that India Ratings & Research (India Ratings) has reaffirmed the Company’s Ratings for:

Instrument Type Size of Issue(million) Rating/Outlook RatingAction
Long-Term IssuerRating - IND BBB- /Stable Affirmed
Term Loan INR 2,776.30 IND BBB- /Stable Affirmed
Fund-based limits INR 3,540 IND BBB- /Stable Affirmed
Non-Fund-based limits INR 1,712 IND A3 Affirmed
Fund-based/nonfund-Basedinterchangeable limits INR 1,737.5 IND BBB- /Stable/INDA3 Affirmed
Term Loan INR 6,443.5^(USD 87.5) IND BBB- /Stable Affirmed
Proposed working capital facilities#* INR 1,047.5 IND BBB- /Stable/INDA3 Affirmed

#The provisional rating of the proposed bank facilities has been converted to final rating in accordance with India Ratings updated policy. This is because the agency notes that debt seniority and general terms and conditions of working capital facilities tend to be uniform across banks, and are not a rating driver.

*Affirmed rating at IND BBB-/Stable/IND A3

^ Reserve Bank of India Reference Rate dated 13[th] September 2021: USD 1= INR 73.64

The Agency undertook a consolidated view of Wockhardt Limited and the rating was given, inter alia , after considering various factors such as monetisation of vaccine contracts which is likely to

==> picture [106 x 46] intentionally omitted <==

==> picture [482 x 30] intentionally omitted <==

==> picture [167 x 46] intentionally omitted <==

boosts prospects, India Business Reporting Above-Industry Growth, Likely sustenance of improvement in Q1 FY22 performance, Commencement of monetisation of R&D Initiatives etc.

For Wockhardt Limited

==> picture [116 x 53] intentionally omitted <==

Debashis Dey Company Secretary

==> picture [106 x 46] intentionally omitted <==

==> picture [482 x 30] intentionally omitted <==